【摘要】：正在臨床病理診斷工作中,免疫組化檢測(cè)是一種必不可少的技術(shù)手段,其染色結(jié)果是病理醫(yī)師作出正確診斷的重要依據(jù)。免疫組化染色步驟繁多,一步操作不當(dāng)就會(huì)影響染色結(jié)果,進(jìn)而影響病理診斷的準(zhǔn)確性。在免疫組化染色過(guò)程中設(shè)立對(duì)照是進(jìn)行染色質(zhì)量控制的重要措施之一,包括陽(yáng)性對(duì)照和陰性對(duì)照。根據(jù)對(duì)照結(jié)果可以判斷免疫組化操作步驟是否正確、使用試劑是否可靠,從而確保技術(shù)最佳化和結(jié)果的有效性。然而,長(zhǎng)期以來(lái)國(guó)內(nèi)外關(guān)于免疫組化對(duì)照的設(shè)立,
[Abstract]:Immunohistochemical examination is an indispensable technique in clinical and pathological diagnosis, and the staining result is an important basis for pathologist to make correct diagnosis. There are many steps of immunohistochemical staining, and improper operation of one step will affect the results of staining, and then affect the accuracy of pathological diagnosis. The establishment of control in the process of immunohistochemical staining is one of the important measures to control the staining quality, including positive control and negative control. According to the control results, we can judge whether the operation steps of immunohistochemistry are correct and whether the reagent is reliable, so as to ensure the optimization of the technique and the effectiveness of the results. However, for a long time, the establishment of immunohistochemical control at home and abroad,
【作者單位】： 江西省人民醫(yī)院病理科;江西省人民醫(yī)院臨床醫(yī)學(xué)研究所;
【分類號(hào)】：R446.6
，

本文編號(hào)：2149908